Ohio’s Third Frontier Project aims to establish a high-tech, knowledge economy in the state by supporting leading-edge research and development. As part of this project, the Biomedical Research Commercialization Program (BRCP) (formerly called the Biomedical Research and Partnership) funds innovative projects with commercial potential in biomedicine and biotechnology. The BRCP has funded several Medical Center programs, including:
- a $6.5 million cardiovascular bioengineering enterprise
- a $1.49 million study on the genetics of gastrointestinal
cancer led by Albert de la Chapelle, MD, PhD, and subcontracted
with Case Western Reserve University
- a $17.1 million biomedical structural, functional and molecular
imaging enterprise led by Michael Knopp, MD, PhD
- a $7.9 million biomedical structural, functional and molecular
imaging enterprise (part 2) led by Michael Knopp, MD, PhD
- $24.9 million for the Ohio Research Scholars Program
- $2.99 million for a Molecular Imaging Center as part of the Wright Center
of Innovation in Biomedical Imaging
- an $8 million comprehensive program for the prevention,
detection and treatment of lung cancer led by Michael
Caligiuri, MD
- a $4.25 million commercialization platform for immunotherapeutic
treatment of multiple sclerosis led by Caroline Whitacre, PhD
- a $556,834 Stem Cell and Tissue Engineering Institute led by
Larry Lasky, MD